← All trials
NCT01002417
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2010
- Primary completion
- Feb 1, 2014
- Completion date
- Feb 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 274
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Health Ever Bio-Tech Co., Ltd.Lead sponsor
- University of California, Los AngelesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.